The clandestine drug laboratory situation in the United States - PubMed

• PMID: 6680736

The clandestine drug laboratory situation in the United States

R S Frank. J Forensic Sci. 1983 Jan.

Abstract

Clandestine, or illegal, laboratories are operated by the criminal element to circumvent legal requirements with the goal of supplying drugs of abuse to the illicit market. Investigation of clandestine drug manufacturing laboratories is a high priority of the U.S. Drug Enforcement Administration (DEA) because elimination of these laboratories will prevent drugs of abuse from reaching the illicit drug traffic. One of the important responsibilities of forensic chemists assisting in investigations of clandestine drug laboratories is to be familiar with the methods of synthesis being used by clandestine laboratory operators. A review of clandestine laboratory seizures during the period of 1978 through 1981 will be provided to familiarize forensic chemists with current information on the types of laboratories being seized in the United States and the methods of synthesis being used.

Similar articles

• Commerce in drugs and chemicals and the detection of clandestine laboratories.

  Haislip GR. Haislip GR. Bull Narc. 1984 Jan-Mar;36(1):25-31. Bull Narc. 1984. PMID: 6564900

• Impurity profiling/comparative analyses of samples of 1-phenyl-2-propanone.

  Krawczyk W, Kunda T, Perkowska I, Dudek D. Krawczyk W, et al. Bull Narc. 2005;57(1-2):33-62. Bull Narc. 2005. PMID: 21338015

• An evolving problem: methamphetamine production and trafficking in the United States.

  Shukla RK, Crump JL, Chrisco ES. Shukla RK, et al. Int J Drug Policy. 2012 Nov;23(6):426-35. doi: 10.1016/j.drugpo.2012.07.004. Epub 2012 Sep 1. Int J Drug Policy. 2012. PMID: 22943831 Review.

• Cooking up solutions to a cooked up menace: responses to methamphetamine in a federal system.

  [No authors listed] [No authors listed] Harv Law Rev. 2006 Jun;119(8):2508-29. Harv Law Rev. 2006. PMID: 16827221 No abstract available.

• Designer drugs: a medicinal chemistry perspective.

  Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17. Ann N Y Acad Sci. 2012. PMID: 22092008 Review.

Cited by

• Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography.

  Nagai T, Kamiyama S, Nagai T. Nagai T, et al. Z Rechtsmed. 1988;101(3):151-9. doi: 10.1007/BF00201110. Z Rechtsmed. 1988. PMID: 3227723

• Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

  Dostalek M, Hadasova E, Hanesova M, Pistovcakova J, Sulcova A, Jurica J, Tomandl J, Linhart I. Dostalek M, et al. Eur J Drug Metab Pharmacokinet. 2005 Jul-Sep;30(3):195-201. doi: 10.1007/BF03190620. Eur J Drug Metab Pharmacokinet. 2005. PMID: 16250257

• The pH Levels of Different Methamphetamine Drug Samples on the Street Market in Cape Town.

  Grobler SR, Chikte U, Westraat J. Grobler SR, et al. ISRN Dent. 2011;2011:974768. doi: 10.5402/2011/974768. Epub 2011 Jun 26. ISRN Dent. 2011. PMID: 21991491 Free PMC article.

• Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

  Quinn DI, Wodak A, Day RO. Quinn DI, et al. Clin Pharmacokinet. 1997 Nov;33(5):344-400. doi: 10.2165/00003088-199733050-00003. Clin Pharmacokinet. 1997. PMID: 9391747 Review.

• Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine.

  Bohn M, Bohn G, Blaschke G. Bohn M, et al. Int J Legal Med. 1993;106(1):19-23. doi: 10.1007/BF01225019. Int J Legal Med. 1993. PMID: 8104465

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information